Advanced search
Publication Cover
Acta Cardiologica Volume 77, 2022 - Issue 4
Submit an article Journal homepage
1,416
Views
2
CrossRef citations to date
0
Altmetric
Editorial

Diagnosis of coronary artery disease: potential complications of imaging techniques

Evangelos Sdogkosa Department of Cardiology, General Hospital of Veroia, Veroia, Greece
,
Andrew Xanthopoulosb Department of Cardiology, University General Hospital of Larissa, Larissa, Greece
,
Grigorios Giamouzisb Department of Cardiology, University General Hospital of Larissa, Larissa, Greece
,
John Skoularigisb Department of Cardiology, University General Hospital of Larissa, Larissa, Greece
,
Filippos Triposkiadisb Department of Cardiology, University General Hospital of Larissa, Larissa, GreeceCorrespondence[email protected]
&
Ioannis Vogiatzisa Department of Cardiology, General Hospital of Veroia, Veroia, Greece
Pages 279-282 | Received 08 Mar 2021, Accepted 28 Mar 2021, Published online: 16 Apr 2021

References

  • Knuuti J, Bengel F, Bax JJ, et al. Risks and benefits of cardiac imaging: an analysis of risks related to imaging for coronary artery disease. Eur Heart J. 2014;35(10):633–638.
  • Tavakol M, Ashraf S, Brener SJ. Risks and complications of coronary angiography: a comprehensive review. Glob J Health Sci. 2012;4(1):65–93.
  • Bottinor W, Polkampally P, Jovin I. Adverse reactions to iodinated contrast media. Int J Angiol. 2013;22(3):149–154.
  • Andreucci M, Solomon R, Tasanarong A. Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention. Biomed Res Int. 2014;2014:741018.
  • Tsai TT, Patel UD, Chang TI, et al. Validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the National Cardiovascular Data Registry Cath-PCI Registry. J Am Heart Assoc. 2014;3(6):e001380.
  • Schonmann C, Brockow K. Adverse reactions during procedures: hypersensitivity to contrast agents and dyes. Ann Allergy Asthma Immunol. 2020;124(2):156–164.
  • Leidig-Bruckner G. Iodinated contrast medium in patients with thyroid disorders. Radiologe. 2019;59(5):413–424.
  • Sicari R, Nihoyannopoulos P, Evangelista A, et al. Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr. 2008;9(4):415–437.
  • Porter T, Mulvagh S, Abdelmoneim S, et al. Clinical applications of ultrasonic enhancing agents in echocardiography: 2018 American Society of Echocardiography Guidelines update. J Am Soc Echocardiogr . 2018;31(3):241–274.
  • Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44(7):1393–1399.
  • Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165.
  • Weinreb JC, Rodby RA, Yee J, et al. Use of intravenous gadolinium-based contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney Foundation. Kidney Med. 2021;3(1):142–150.
  • Harvey B, Gowda V, Cheng G. Gadolinium deposition disease: a new risk management threat. J Am Coll Radiol. 2020;17(4):546–550.
  • Lawler PR, Afilalo J, Eisenberg MJ, et al. Comparison of cancer risk associated with low-dose ionizing radiation from cardiac imaging and therapeutic procedures after acute myocardial infarction in women versus men. Am J Cardiol. 2013;112(10):1545–1550.
  • Eisenberg MJ, Afilalo J, Lawler PR, et al. Cancer risk related to low-dose ionizing radiation from cardiac imaging in patients after acute myocardial infarction. CMAJ. 2011;183(4):430–436.
  • Ramanathan S, Ladumor SB, Francis W, et al. Incidental non-cardiac findings in coronary computed tomography angiography: is it worth reporting? J Clin Imaging Sci. 2019;9:40.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A worldwide pioneer in biotechnology.
Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.